Company news
Tiumbio Co., Ltd. (KRX:321550) news
Tiumbio Co., Ltd. news releases on 6ix. Latest, May 31, 2026: TiumBio to Present Phase 2a Interim Data Highlighting Differentiated Clinical Profile…
Press releases & updates
TiumBio to Present Phase 2a Interim Data Highlighting Differentiated Clinical Profile for Tosposertib(TU2218) plus Pembrolizumab in First-Line R/M HNSCC at ASCO 2026
May 31, 2026
TiumBio and Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial of 'Merigolix (TU2670/DW4902)' for Uterine Fibroids
May 7, 2025
TiumBio's Partner Hansoh Pharma Expands Indications for Merigolix (HS-10518) with Initiation of ART (Assisted Reproductive Technology) Development
March 20, 2025